Molecular changes in nonalcoholic fatty liver disease could serve as potential therapeutic targets to halt the cells’ progression to liver cancer.
Crohn’s disease, FODMAP, SUN1 gene and more: Research updates from Michigan Medicine clinicians.
Known as histotripsy, the device not only kills cancer cells but also stimulates the immune system as an added defense.
Trial will evaluate the safety and efficacy of histotripsy against liver tumors at eight U.S. sites.
The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.
A hepatologist comments on the new USPSTF guidelines for detecting hepatitis B in non-pregnant adults and adolescents.